©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Isolation of cDNA Clones Encoding Eight Different Human G Protein Subunits, Including Three Novel Forms Designated the , , and Subunits (*)

(Received for publication, March 3, 1995; and in revised form, June 7, 1995)

Kausik Ray (1)(§) Charles Kunsch (2) Laura M. Bonner (2) Janet D. Robishaw (1)(¶)

From the  (1)Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822 and (2)Human Genome Sciences Inc., Rockville, Maryland 20850

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

With the growing awareness that the G protein beta and subunits directly regulate the activities of various enzymes and ion channels, the importance of identifying and characterizing these subunits is underscored. In this paper, we report the isolation of cDNA clones encoding eight different human subunits, including three novel forms designated (4), , and . The predicted protein sequence of (4) shares the most identity (60-77%) with (2), (3), and (7) and the least identity (38%) with (1). The (4) is modified by a geranylgeranyl group and is capable of interacting with both beta(1) and beta(2) but not with beta(3). The predicted protein sequence of shows only modest to low identity (35-53%) with the other known subunits, with most of the differences concentrated in the N-terminal region, suggesting may interact with a unique subclass of alpha. The is modified by a geranylgeranyl group and is capable of interacting with beta(1) and beta(2) but not with beta(3). Finally, the predicted protein sequence of shows the most identity to (1) (76% identity) and the least identity to the other known (33-44%). Unlike most of the other known subunits, is modified by a farnesyl group and is not capable of interacting with beta(2). The close resemblance of to (1) raises intriguing questions regarding its function since the mRNA for is abundantly expressed in all tissues tested except for brain, whereas the mRNA for (1) is expressed only in the retina where the protein functions in phototransduction.


INTRODUCTION

Intracellular transmission of extracellular signals are most commonly mediated by a family of guanine nucleotide-binding proteins (G proteins) that couple with various receptors and effectors to produce appropriate cellular responses. The G proteins are heterotrimers, composed of alpha, beta, and subunits. In response to binding of the appropriate ligand, the receptor stimulates the exchange of bound GDP for GTP on the alpha subunit, resulting in the dissociation of the alpha subunit from the beta and subunits. The GTP-bound alpha subunit has been shown to directly regulate the activity of downstream effectors (1, 2, 3) . Recently, it has been shown that the beta subunits, which exist as a tightly associated complex in vivo(1) , can also regulate the activity of a specific subset of downstream effectors, including adenylyl cyclase subtypes II and IV, phospholipase A2, phospholipase C subtypes beta1, 2, and 3, and K and Ca channels(4, 5, 6) . Thus, the G protein alpha and beta subunits produce bifurcating signals that regulate effector function. Moreover, the beta subunits can directly bind to receptors (7) and can increase agonist-dependent phosphorylation and desensitization of receptors by directly interacting and recruiting the beta-adrenergic receptor kinases to the membrane(8, 9) . Thus, the beta subunits play prominent roles in both effector regulation and receptor recognition. As the number of alpha, beta, and subunits continues to grow, the task of unraveling the subunit composition and function of individual G proteins is becoming more complex.

Both the beta and subunits belong to large multigene families. Complete cDNAs encoding five distinct mammalian beta subunits (beta(1)-beta(5)) have been identified thus far (10) . A rat heart cDNA identified recently may encode a sixth beta subunit, which is 96% identical to the human beta(3) subunit (11) . At the amino acid level, the beta subunits are highly conserved. In contrast, the subunits are much more divergent, suggesting this may determine the functional specificity of the beta subunit complex. Complete cDNAs representing five different subunits have been reported with the isolation of the (1) subunit from bovine retina(12) , the (2), (3), and (7) subunits from bovine brain(13, 14, 15, 16) , and the (5) subunit from bovine and rat liver (17) . (^1)The existence of a putative (4) subunit has also been reported with the isolation of a PCR (^2)fragment from mouse kidney and retina (15) . In the present paper, we report the isolation and characterization of cDNA clones encoding the human homologs of the five known (1), (2), (3), (5), and (7) subunits as well as three previously unknown (4), , and subunits. (^3)Comparison of the (4), , and subunits reveals some interesting amino acid homologies. Of particular interest, the subunit shows only a low level of homology (35-53%) with the other subunits, suggesting the existence of a new subclass of subunits. On the other hand, the subunit shows a high level of homology (76%) to the (1) subunit. This close resemblance to the (1) subunit raises important questions regarding the function of the subunit since the mRNA for is expressed in a wide variety of tissues, whereas the mRNA for (1) is expressed only in the retina where it functions in phototransduction. In addition to presenting their cDNA and deduced amino acid sequences, we examine the tissue distribution of the (4), , and subunits and show their selective interactions with the beta(1), beta(2), and beta(3) subunits.


EXPERIMENTAL PROCEDURES

Isolation and Analysis of cDNA Clones Encoding Human G Protein Subunits

To obtain cDNAs encoding the human G protein subunits, a human cDNA data base consisting of approximately 300,000 expressed sequence tags (ESTs) was searched for homologous sequences to the known bovine, rat, and mouse subunits by BLASTN and TBLASTN sequence alignment algorithms(18) . The EST method involves automated DNA sequence analysis of random cDNA clones (19, 20) from a variety of human tissue and cell lines. For each human gene, several ESTs were identified from multiple cDNA libraries. These cDNA libraries were constructed by cloning oligo(dT)-primed cDNAs into the cloning vector pBluescript II-SK (Stratagene). Nearly all of the identified ESTs originated from a full-length cDNA. For each human clone, a single cDNA was chosen, sequenced to completion, and used for further study.

Northern Blot Hybridization

A Northern blot containing 2 µg of poly(A) mRNA prepared from several human tissues (Clontech) was hybridized at 42 °C in 50% formamide, 5 times SSPE (20 times SSPE = 3 M NaCl, 0.2 M sodium phosphate, 0.02 M EDTA, pH 7.4), 0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine albumin serum, 2% SDS, and 100 µg/ml sheared salmon sperm DNA. Fragments of the (4), , and cDNAs were isolated by double digestion of the corresponding cDNA clones in pBluescript vector with EcoRI and XhoI restriction enzymes. Probes were generated from the purified fragments by random priming with the Klenow fragment of DNA polymerase I in the presence of dCTP (3,000 Ci/mmol, Amersham). After hybridization, high stringency washes were performed at 65 °C in 0.1 times SSC (1 times SSC is 0.15 M sodium chloride, 0.015 M sodium citrate), 0.1% SDS. Blots were exposed for the indicated times at -80 °C with an intensifying screen.

Construction of Plasmids

For transcription and translation purposes, the coding sequences of the human beta(1), beta(2), (4), , and were subcloned into either pGEM (Promega) or pBluesript (Stratagene) vectors by PCR amplification of the corresponding cDNA clones using the appropriate oligonucleotide primers. The coding sequences were then completely sequenced to confirm that no errors were introduced as the result of PCR amplification. In the case of the beta(3) subunit, a 1050-bp fragment of the human beta(3) cDNA clone (21) was excised with ApaI and subcloned into the ApaI site of the pBluescript KS vector.

In Vitro Transcription and Prenylation Assays

1 µg of plasmid DNA was linearized and transcribed with T7 (for the (2), , or subunits) or T3 (for the (4) subunit) RNA polymerase. Transcription was performed as described in the protocol provided with the RNA capping kit (Stratagene). To assess translation, 4 µg of the resulting RNA was translated in a 50-µl reaction in the TNT-coupled rabbit reticulocyte lysate system (Promega), using 20 µCi of [S]methionine (Amersham Corp.). To examine prenylation, RNA was translated in the TNT-coupled rabbit reticulocyte lysate system supplemented with cold methionine, using 50 µCi of either [^3H]farnesyl pyrophosphate (FPP) or [^3H]geranylgeranyl pyrophosphate (GGPP). After translations were allowed to proceed for 2 h at 30 °C, a 10-µl aliquot of the S-labeled translation mix or a 25-µl aliquot of the ^3H-labeled translation mix was dissolved in electrophoresis sample buffer and subjected to 15% SDS-polyacrylamide gel electrophoresis(22) .

In Vitro Translation and Tryptic Proteolysis

beta interaction was assessed by a tryptic proteolysis assay. 1 µg of plasmid DNA for each of the beta and subunits was cotranscribed and cotranslated in the TNT-coupled rabbit reticulocyte lysate system (Promega). The plasmid DNA for each of the subunits was linearized to limit the generation of translated products of higher molecular weight. Whereas both the (2) and (4) subunits were translated efficiently in this system, the and subunits were translated at significantly lower levels. To increase levels of the and subunits, 2 µg of capped RNA were added to the cotranscribed beta- mix. Alternatively, and subunits that had been translated separately were added to the cotranslated beta- mix. For tryptic digestion, 5- or 10-µl aliquots of the cotranslated beta- mix were digested by addition of 1 µl of trypsin (1 µg) in a final volume of 20 µl (with 50 mM Na-HEPES, pH 8.0). After incubation for 1 h at 30 °C, the digestions were stopped by addition of Laemmli sample buffer and boiling for 3 min. Protected fragments of beta subunits were visualized by running samples on 15% SDS-polyacrylamide gel electrophoresis gels. After electrophoresis, gels were fixed in 40% methanol, 10% acetic acid mix, soaked in ENHANCE (DuPont NEN), and dried. The dried gels were exposed for 8-48 h at -80 °C.


RESULTS

Isolation and Classification of cDNA Clones Encoding Human G Protein Subunits

In the course of a large scale DNA sequencing project dedicated to the identification and characterization of ESTs from the human genome, approximately 300,000 cDNA clones were partially sequenced from a variety of tissue- or cell-specific cDNA libraries. Comparison of this data base with the protein sequence data base revealed at least 49 ESTs, originating from eight distinct human genes, that showed significant identity to bovine, rat, and mouse cDNA clones encoding the subunits. Complete sequencing of a representative cDNA clone for each of the eight groups allowed a comparison with the known subunits from other species (Table 1). Based on their striking identity at the amino acid level (97-100%), we determined that five of the eight cDNA clones represent the human homologs of the (1), (2), (3), (5), and (7) subunits previously cloned from other species. Further, we concluded that the remaining three of the eight cDNA clones represent novel subunits based on the findings that 1) these cDNA clones encode proteins that show a significantly lower degree of identity to known subunits at the amino acid level (30-97% identity) and 2) the amino acid differences that were present were distributed throughout the proteins, indicating that they did not arise by alternative splicing of known subunits. Since the predicted amino acid sequence of one of the three cDNA clones showed marked identity (97%) to a PCR fragment of a putative mouse (4) subunit(15) , we believe that this cDNA clone represents the human homolog of the mouse (4) subunit, which has never been cloned. Accordingly, these cDNA clones were designated the (4), , and subunits.



The complete nucleotide and deduced amino acid sequences of the newly identified (4), , and subunits are shown in Fig. 1Fig. 2Fig. 3. In the case of the (4) subunit, partial cDNA clones were isolated from various cDNA libraries, including jurkat T-cell, bone marrow, prostate, 6-week-old embryo, and adrenal gland tumor libraries, by EST sequencing. The longest 689-bp cDNA reported here was isolated from the adrenal gland tumor library. The cDNA includes 98 and 365 bp of 5`- and 3`-untranslated (UTR) sequences, respectively (Fig. 1). The first ATG codon at position 99 has the characteristics of a translation initiator codon with the expected purines at positions -3 and +4(23) . A second ATG codon at position 111 lacks the expected purines, making it less likely to be the initiator codon. A typical polyadenylation signal (AATAAA) was not found, but a polyadenine sequence was observed near the 3`-end of the cDNA. In the case of the subunit, several partial ESTs were identified in a variety of human cDNA libraries, including T-cell lymphoma, fetal heart, stimulated monocyte, osteoclastoma, stromal cell line TF274, placenta, neutrophil, bone marrow, prostate, and hippocampus. The longest 1213-bp cDNA was isolated from the T-cell lymphoma library. The cDNA includes 23 and 986 bp of 5`- and 3`-UTR sequences, respectively (Fig. 2). The long 3`-UTR possesses a poly(A) tail, a polyadenylation signal toward the 3`-end, and several A(T)(n)A motifs implicated in mRNA stability(24) . In the case of the subunit, partial cDNA clones were detected in a number of human libraries, including pineal gland, testes, thymus tumor, stromal cell line TF274, 6-week-old embryo, and platelet-derived growth factor-induced endothelial cell libraries. The longest 654-bp cDNA reported here was isolated from the testes library, which includes 106 and 326 bp of 5`- and 3`-UTR sequences, respectively (Fig. 3). The 3`-UTR contains a polyadenylation signal and a poly(A) tail toward the 3`-end.


Figure 1: Nucleotide and predicted amino acid sequence of the human (4) subunit. The first ATG codon of the open reading frame starts at position 99. Amino acids are denoted by single-letter codes.




Figure 2: Nucleotide and predicted amino acid sequence of the human subunit. The open reading frame starts at position 24. Amino acids are denoted by single-letter codes. A potential polyadenylation signal (AATAAA) is underscored with solid lines.




Figure 3: Nucleotide and predicted amino acid sequence of the human subunit. The open reading frame starts at position 108. Amino acids are denoted by single-letter codes. A potential polyadenylation signal (AATAAA) is underscored with solid lines.



Comparison of Subunits

Comparison of the predicted protein sequences of the newly identified (4), , and subunits to the human homologs of the (1), (2), (3), (5), and (7) subunits revealed significant homology (Fig. 4). For the (4) subunit, the homology ranged from a low of 38% for the (1) subunit to a high of 77% for the (2) subunit. For the subunit, the homology ranged from a low of 35% for the (1) subunit to a high of only 53% for the (2), (5), and (7) subunits. This relatively low level of homology suggests the subunit may represent a new subclass that is only distantly related to the other subunits. Finally, for the subunit, the homology ranged from a low of 33 to 44% for the (2), (3), (5), and (7) subunits to a high of 76% for the (1) subunit. This close resemblance to the (1) subunit is particularly interesting since the (1) subunit is the most diverse of the subunits identified thus far.


Figure 4: Comparison of the human subunits. An alignment of the human (1), (2), (3), (4), (5), (7), , and was made with the GCG PILEUP program. Regions I, II, and III are overlined and represent the alpha- interaction region, beta- interaction region, and CAAX box, respectively (see text for explanation). Regions A, B, and C represent regions that are highly conserved in all subunits. Identical amino acid residues are boxed. Amino acid differences between the human and bovine (1) and (7) subunits are underlined.



Most of the homology among the subunits was concentrated in several discrete regions (Fig. 4). The N-terminal region of the (4), , and subunits is the most divergent at the amino acid level (region I), consistent with the newly defined role of this region in determining the specificity of the interaction between the and alpha subunits(25) . An internal region of 14 amino acids, which has been implicated in determining the specificity of the interaction between the and beta subunits(26) , is conserved to varying degrees between the (4), , and subunits (region II). Finally, the C-terminal region containing the CAAX sequence (C = cysteine; A = aliphatic; X = leucine, serine, or methionine), which has been shown to direct prenylation and carboxyl-methylation of these proteins(27, 28) , is conserved in the (4), , and subunits (region III). Three other regions that are highly conserved in mammalian and Drosophila subunits (29) are also conserved in the (4), , and subunits (regions A, B, C). Although their roles have not yet been established, these regions may be important in generating similar conformations of the subunits.

Prenylation of the , , and Subunits

Prenylation is a post-translational modification that involves the addition of a C15 farnesyl or a C20 geranylgeranyl group to proteins terminating in a CAAX sequence. To determine the type of prenyl group added to these proteins, cDNAs for the (4), , and subunits were transcribed and translated in the TNT-coupled rabbit reticulolysate system, which has been shown to possess the necessary enzymes for utilizing FPP or GGPP as precursors for the prenylation reaction(28) . As shown in Fig. 5A, translation in the presence of [S]methionine gave protein products with the expected molecular masses (6-8 kDa) of the subunits on SDS-polyacrylamide gels. As shown in Fig. 5B, equivalent translation in the presence of [^3H]GGPP showed incorporation of ^3H label into the (4) and subunits but not into the subunit. In contrast, translation in the presence of [^3H]FPP showed incorporation of ^3H label into the subunit but not into the (4) and subunits. Thus, on the basis of these results, the (4) and subunits are modified by a geranylgeranyl group, whereas the subunit is modified by a farnesyl group.


Figure 5: Prenylation of the (4), , and subunits in vitro. Translations were performed in the TNT-coupled rabbit reticulocyte lysate system in the presence of [S]methionine (panelA) and [^3H]FPP or [^3H]GGPP (panelB).



Tissue Distribution of the , , and Subunits

To determine the size and distribution of the mRNAs encoding the (4), , and subunits, poly(A)-enriched RNA from various human tissues was fractionated by agarose gel electrophoresis and transferred to nylon membrane. Subsequently, the membrane was hybridized sequentially with radiolabeled cDNA probes specific for (4), , and . As shown in Fig. 6A, the (4) probe hybridized to three mRNA species of 2.0, 5.0, and 7.0 kb at high stringency. The longest mRNA species of 7.0 kb is found in skeletal muscle and very faintly in cardiac muscle, indicating that this transcript may be muscle-specific. The 5.0-kb mRNA species is found predominantly in brain, and less extensively in kidney and pancreas. The smallest mRNA species of 2.0 kb is found in brain, kidney, and pancreas. Thus, the three mRNA species encoding the (4) subunit are expressed in a limited number of human tissues, with the relative amounts of each mRNA varying widely. While the origin of these mRNA species is not known, it is reasonable to speculate that they are derived from one gene by alternative splicing and/or polyadenylation. Likewise, the significance of the large size of these mRNA species is not clear in view of the small size of the encoded protein but may reflect complex transcriptional and/or translational regulatory features. As shown in Fig. 6B, the probe hybridized to a single mRNA species of 1.4 kb, which is expressed at high levels in heart, brain, placenta, lung, skeletal muscle, kidney, liver, and pancreas. Thus, in contrast to the (4) subunit, the single mRNA species encoding the subunit is abundantly and ubiquitously expressed. Finally, as shown in Fig. 6C, the probe hybridized to two mRNA species of 1.0 and 1.2 kb. Both mRNA species are expressed at high levels in heart, placenta, lung, skeletal muscle, kidney, and pancreas, at lower levels in liver, and at undetectable levels in brain. Thus, in contrast to both the (4) and subunits, the two mRNA species encoding the subunit are not expressed at detectable levels in brain but are expressed in several other tissues. The lack of expression of the subunit in the brain is surprising since all of the other subunits identified thus far have been shown to be expressed in brain with the exception of the (1) subunit, which is expressed only in the retina. In view of their striking amino acid homology, it will be interesting to determine the basis for the lack of expression of the (1) and subunits in the brain.


Figure 6: Northern blotting analysis of the (4), , and subunits. Each lane represents 2.0 µg of poly(A)-enriched mRNA from different human tissues (Clontech). Lane 1, heart; lane 2, brain; lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, pancreas. The positions of RNA size markers are indicated on the right. The blot was hybridized sequentially with radiolabeled probes specific for (4) (panel A), (panel B), or (panel C), respectively. Blots were exposed at -80 ° for 4 days for (4) and overnight for and .



Selective Interaction of the , , and Subunits with Various beta Subunits

To determine which combinations of beta subunits and newly identified subunits are capable of forming functional dimers, we used a previously developed tryptic digestion method(30) . This method is based on the finding that in vitro translated beta monomers are cleaved at numerous sites by trypsin, whereas in vitro translated beta dimers are cleaved at a single site, resulting in the appearance of a 26-kDa fragment of the beta subunit that is resistant to further digestion by trypsin. Thus, the appearance of a stable 26-kDa protected fragment can be used as a marker of beta dimerization. Included as a positive control for this series of studies was the (2) subunit, which has been shown to form dimers with both the beta(1) and beta(2) subunits, but not with the beta(3) subunit, by this (30) and other corroborating (31, 32, 33) methods.

As shown in Fig. 7, the in vitro translated beta(1), beta(2), and beta(3) monomers were almost completely digested by trypsin (panelsA-C). In contrast, in vitro translated mixtures of the beta(1) subunit and either the (2), (4), , or subunit yielded a 26-kDa protected fragment when digested by trypsin under identical conditions (panelA). Likewise, in vitro translated mixtures of the beta(2) subunit and either the (2), (4), or subunit produced a 26-kDa protected fragment when digested by trypsin (panelB). However, when an in vitro translated mixture of the beta(2) subunit and the subunit was digested by trypsin, no such fragment was generated (panelB), even though the levels of the beta(1) subunits and the beta(2) subunits in the in vitro translated mixtures were comparable. Taken together, these results indicate that the beta(1) subunit is able to form dimers with the (4), , and subunits, whereas the beta(2) subunit is able to form dimers with the (4) and subunits but not with the subunit. The inability of the beta(2) subunit to form a dimer with the subunit is particularly interesting since the subunit most closely resembles the (1) subunit at the amino acid level, and the (1) subunit is unable to form a dimer with the beta(2) subunit(30) . Finally, no protected fragment was generated when in vitro translated mixtures of the beta(3) subunit and the (2), (4), , or subunit were digested by trypsin (panelC). However, this result is more difficult to interpret since no positive control exists for the beta(3) subunit at the present time. Thus, it is not certain whether this result indicates that the beta(3) subunit is not able to form dimers with any of the known subunits or whether the beta(3) subunit is able to form dimers with some of the known subunits but that tryptic digestion of the resulting beta(3) dimers does not generate a protected fragment of beta(3). In this regard, the beta(3) subunit has been reported to contain one more potential tryptic digestion site (lysine 177) in the 26-kDa fragment than the beta(1) or beta(2) subunits(30) . Thus, if trypsin cleaves at lysine 177 in addition to arginine 129, then a 26-kDa fragment of the beta(3) subunit may not be observed. To rule out this possibility, in vitro translated mixtures of the beta(3) subunit and the (2), (4), , or subunits were digested by Arg-C, a protease that cleaves only at arginine residues (data not shown). However, again, no protected fragments of the beta(3) subunit were observed, consistent with the interpretation that the beta(3) subunit is not able to form dimers with any of the known subunits. Taken together, these results indicate that the (4), , and subunits have the ability to selectively associate with particular beta subunits, consistent with previous results on the (1), (2), (3), (5), and (7) subunits(30, 31, 32, 33) . In this regard, an examination of the amino acids that are common to the (1) and subunits, but are not common to the (2), (4), and subunits, may shed further light on the regions of the subunit that are important for forming dimers with the beta(2) subunit.


Figure 7: Tryptic analysis of beta- dimer formation. In vitro translations were performed in the presence of [S]methionine. Subsequently, in vitro translated beta monomers or cotranslated beta- mixtures were incubated in the absence or presence of trypsin, as indicated. The arrowhead indicates the position of the 26-kDa protected fragment of beta.




DISCUSSION

Diversity and Distribution of Subunits

With the recent description of additional roles of the G protein beta dimers in signal transduction(4, 5, 6, 7, 8, 9) , the importance of identifying and characterizing these proteins is underscored. Since the subunits are thought to determine the functional specificity of the beta dimers, most of our attention has focused on these proteins. With the cloning of the (4), , and subunits in the present paper, the subunit family consists of a minimum of 10 members(12, 13, 14, 15, 16, 17) .^3 Analysis of the amino acid sequence conservation suggests that the subunit family can be divided into four distinct subclasses, one containing the (1) and subunits, a second containing the (2), (3), (4), and (7) subunits, a third containing the (5) subunit, and a fourth containing the subunit. Although the subclasses exhibit <50% homology to each other, the division of the subunit family into these subclasses is based not only on amino acid homology but also to some extent on functional similarities. Thus, within a subclass, members display similar post-translational modifications and similar abilities to interact with the beta and alpha subunits of the G proteins. For example, the (1) and subunits, which comprise one subclass, are modified by a farnesyl group, do not interact with the beta(2) subunit, and at least in the case of the (1) subunit, do not interact with the alpha(o) subunit(25) . In contrast, the (2), (3), (4), and (7) subunits, which comprise another subclass, are modified by a geranylgeranyl group, interact with the beta(2) subunit, and at least in the case of the (2), (3), and (7) subunits, interact with the alpha(o) subunit (34) . (^4)It is likely that the total number of different subunits has not yet been uncovered and that even more members of this family will be identified in the future.

Among members of the subunit family, there are marked differences in the tissue distribution. Some members, such as the (1), (2), (3), and (4) subunits, are restricted to one or a few tissues, whereas others, such as the (5), (7), , and subunits, are expressed in a wide variety of tissues (16) . Furthermore, in most cell types within a tissue, only a certain subset of subunits is present(35, 36) . It is likely that such differences in distribution may be important in limiting the number of combinatorial associations of the alpha, beta, and subunits into functionally distinct G proteins. In this regard, differences in the subcellular localization of various subunits have also been reported(37) . It is likely that particular alpha and beta subunits will be found to share these patterns of subcellular localization in future studies.

Significance of Prenylation of Subunits

Two different prenyl groups are added to proteins terminating in CAAX sequences, with the residue in the -X position playing a major role in determining which type of prenyl group is added(38) . In the case of (1) subunit in which the amino acid in the -X position is a serine, the protein is modified by a C15 farnesyl group(28) . On the other hand, in the case of the (2), (3), (5), and (7) subunits, in which the amino acid in the -X position is leucine, these proteins are modified by a C20 geranylgeranyl group(27) .^4 Consistent with these earlier results, we show in the present study that the (4) and subunits, both containing a leucine in the X position, are modified by a geranylgeranyl group, whereas the subunit, containing a serine in the X position, is modified by a farnesyl group.

The functional significance of adding a geranylgeranyl versus a farnesyl group has not been addressed for this family of proteins. However, the idea that different types of prenyl groups impart distinct functional properties is suggested by analysis of retinal and brain beta subunits. In particular, striking differences between the retinal and brain beta subunits have been reported in terms of membrane association(39) , interaction with G protein alpha subunits(25) , receptors(40) , receptor kinases(9) , and effectors(32) . Since the retinal and brain beta subunits share a common beta(1) subunit, these differences would appear to be due to their unique subunits. In this regard, the retinal beta subunits contain a farnesylated (1) subunit, whereas the brain beta subunits are composed mainly of a mixture of the geranylgeranylated (2), (3), and (7) subunits. Consistent with the idea that farnesyl groups are less hydrophobic than geranylgeranyl groups, the retinal beta(1) subunits can be readily eluted from membranes at low ionic strength(39) , whereas the brain beta(2), beta(3), and beta(7) subunits require detergents to be eluted from membranes. However, it is not yet known whether the difference in membrane association is due to a difference in the primary structures of the subunits, the nature of the prenyl group added to the proteins, or some combination of both. In this regard, it will be interesting to examine the subunit. Since the subunit shares several unique structural features of the (1) subunit that are not observed in any other subunit, including modification by a farnesyl group, we predict that the (1) and subunits may represent a unique subclass of the subunit family that interacts reversibly with the membrane.

Discrimination of beta Subunits

The formation of distinct beta dimers as the result of selective interactions of the 6 beta and 10 subunits identified thus far is likely to contribute to the specificity of G protein-mediated signaling pathways. In the present study, we show the formation of distinct beta dimers as the result of selective interactions of the (4), , and subunits with the beta(1), beta(2), and beta(3) subunits. To put these results in context, we show a summary of the known beta- interactions in Table 2. Thus, similar to the (2), (3), (5), and (7) subunits(30, 31, 32, 33) , the (4) and subunits are able to interact with the beta(1) and beta(2) subunits but not with the beta(3) subunit. On the other hand, the subunit is more similar to the (1) subunit in that they interact with the beta(1) subunit but not with the beta(2) or beta(3) subunits(30, 31) . Intriguingly, a short region of the (1) subunit, which has been shown recently to discriminate between the beta(1) and beta(2) subunits(26) , is found to be highly conserved in the subunit (region II in Fig. 4). Future studies will focus on those amino acids in this region that are unique to the (1) and subunits with respect to their ability to selectively associate with the beta(1) and beta(2) subunits. One such candidate is cysteine 36 in the (1) and subunits. Cross-linking studies have shown that cysteine 36 in the (1) subunit is in close physical proximity to cysteine 25 in the beta(1) subunit(41) . Although recent reports have suggested that the region surrounding cysteine 25 in the beta(1) and beta(2) subunits does not confer the selectivity of interaction with the (1) subunit(31, 42) , these results do not rule out the possibility that multiple domains of the beta subunit may be necessary to confer selectivity. Thus, it is tempting to speculate that cysteine 36 and/or adjoining residues in the (1) and subunits may confer the selectivity of interaction with the beta(1) and beta(2) subunits. However, since the (1), (2), (3), (4), , or subunits do not appear to interact with the beta(3) subunit, it is clear that the region surrounding cysteine 36 is not the only important region of the subunit in determining the selectivity of beta interaction. Identification of other regions in the subunits that confer selective interactions will be aided by the isolation of a subunit that interacts with the beta(3) subunit. In this regard, Lee and colleagues (39) have purified a beta subunit complex from the cone cells of retina that is composed of the beta(3) subunit and an unidentified subunit.^3 Although the identity of this novel subunit is not yet known, it does not appear to be the (4) subunit since the results of the present study suggest that the (4) subunit is not capable of forming a dimer with the beta(3) subunit, as predicted by Kleuss and colleagues(43) .



Discrimination of alpha Subunits

The existence of numerous alpha, beta, and subunits raises important questions regarding the assembly of individual G proteins. Recently, we showed that the assembly of G proteins is determined by the interactions of the more structurally diverse alpha and subunits(25, 34, 44) . In this regard, we provided evidence that the subunit can directly interact with the alpha subunit (34) and that the region responsible for specifying interaction with the alpha subunit can be mapped to a 15-amino acid stretch at the N terminus of the subunit(25) . Consistent with these findings, a comparison of the N-terminal regions of the (1), (2), (4), (5), (7), and subunits revealed a high degree of divergence (see Fig. 4). Interestingly, however, a similar comparison of the N-terminal regions of the (1) and subunits showed an unexpectedly high degree of similarity. Although the significance of this is not yet known, it may suggest the existence of a new alpha subunit that shares considerable homology with the alpha(t) subunit (transducin) in retina but is expressed in tissues other than retina.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) U31382[GenBank], U31383[GenBank], and U31384[GenBank].

§
Recipient of a postdoctoral fellowship from the American Heart Association, Pennsylvania affiliate.

To whom correspondence should be addressed: Weis Center for Research, Geisinger Clinic, 100 North Academy Ave., Danville, PA 17822. Tel.: 717-271-6684; Fax: 717-271-6701.

(^1)
The trend in the literature has been to name the subunits in the order in which they were cloned. Accordingly, the (6) subunit (13) has been renamed the (2) subunit.

(^2)
The abbreviations used are: PCR, polymerase chain reaction; EST, expressed sequence tag; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; UTR, untranslated region; bp, base pair(s); kb, kilobase(s).

(^3)
The cloning and sequencing of two new subunits, which are distinct from any of the subunits described in this manuscript, were described while this manuscript was under review (45, 46) .

(^4)
M. Rahmatullah and J. D. Robishaw, unpublished results.


ACKNOWLEDGEMENTS

The contribution of members of the DNA sequencing facility at Human Genome Sciences is acknowledged. Sequence information for one of the subunits was provided by the Institute for Genomic Research. Human tissue for the construction of cDNA libraries was provided by the Cooperative Human Tissue Network, an agency funded by NCI, National Institutes of Health.


REFERENCES

  1. Gilman, A. G. (1987) Annu. Rev. Biochem. 56,615-649 [CrossRef][Medline] [Order article via Infotrieve]
  2. Simon, M. I., Strathmann, M. P., and Gautam, N. (1991) Science 252,802-808 [Medline] [Order article via Infotrieve]
  3. Birmbaumer, L. (1992) Cell 71,1069-1072 [Medline] [Order article via Infotrieve]
  4. Tang, W. J., and Gilman, A. G. (1991) Science 254,1500-1503 [Medline] [Order article via Infotrieve]
  5. Wickman, K. D., Iniguez-Lluhi, J. A., Davenport, P. A., Taussig, R., Krapivinsky, G. B., Linder, M. E., Gilman, A. G., and Clapham, D. E. (1994) Nature 368,255-257 [CrossRef][Medline] [Order article via Infotrieve]
  6. Clapham, D. E., and Neer, E. J. (1993) Nature 365,403-406 [CrossRef][Medline] [Order article via Infotrieve]
  7. Phillips, W. J., and Cerione, R. A. (1992) J. Biol. Chem. 267,17032-17039 [Abstract/Free Full Text]
  8. Haga, K., and Haga, T. (1992) J. Biol. Chem. 267,2222-2227 [Abstract/Free Full Text]
  9. Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J. (1992) Science 257,1264-1267 [Medline] [Order article via Infotrieve]
  10. Watson, A. J., Katz, A., and Simon, M. I. (1994) J. Biol. Chem. 269,22150-22156 [Abstract/Free Full Text]
  11. Ray, K., and Robishaw, J. D. (1994) Gene (Amst.) 149,337-340 [CrossRef][Medline] [Order article via Infotrieve]
  12. Hurley, J. B., Fong, H. K. W., Teplow, D. B., Dreyer, W. J., and Simon, M. I. (1984) Proc. Natl. Acad. Sci. U. S. A. 81,6948-6952 [Abstract]
  13. Robishaw, J. D., Kalman, V. K., Moomaw, C. R., and Slaughter, C. A. (1989) J. Biol. Chem. 264,15758-15761 [Abstract/Free Full Text]
  14. Gautam, N., Baetscher, M., Aebersold, R., and Simon, M. I. (1989) Science 244,971-974 [Medline] [Order article via Infotrieve]
  15. Gautam, N., Northup, J., Tamir, H., and Simon, M. I. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,7973-7977 [Abstract]
  16. Cali, J. J., Balcueva, E. A., Rybalkin, I., and Robishaw, J. D. (1992) J. Biol. Chem. 267,24023-24027 [Abstract/Free Full Text]
  17. Fisher, K. J., and Aronson, N. N. (1992) Mol. Cell. Biol. 12,1585-1591 [Abstract]
  18. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215,403-410 [CrossRef][Medline] [Order article via Infotrieve]
  19. Adams, M. D., Kelley, J. M., Gocayne, M., and Dubnick, M. H. (1991) Science 252,1651-1656 [Medline] [Order article via Infotrieve]
  20. Adams, M. D., Dubnick, M., Kerlavage, A. R., Moreno, R., Kelley, J. M., Utterback, T. R., Nagle, J. W., Fields, C., and Venter, J. C. (1992) Nature 355,632-634 [CrossRef][Medline] [Order article via Infotrieve]
  21. Levine, M. A., Smallwood, P. M., Moen, P. T., Helman, L. J., and Ahn, T. G. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,2329-2333 [Abstract]
  22. Laemmli, U. K. (1970) Nature 227,680-685 [Medline] [Order article via Infotrieve]
  23. Kozak, M. (1991) J. Biol. Chem. 266,19867-19870 [Free Full Text]
  24. Shaw, G., and Kamen, R. (1986) Cell 46,659-667 [Medline] [Order article via Infotrieve]
  25. Rahmatullah, M., Ginnan, R., and Robishaw, J. D. (1995) J. Biol. Chem. 270,2946-2951 [Abstract/Free Full Text]
  26. Spring, D. J., and Neer, E. J. (1994) J. Biol. Chem. 269,22882-22886 [Abstract/Free Full Text]
  27. Maltese, W. A., and Robishaw, J. D. (1990) J. Biol. Chem. 265,18071-18074 [Abstract/Free Full Text]
  28. Sanford, J., Codina, J., and Birnbaumer, L. (1991) J. Biol. Chem. 266,9570-9579 [Abstract/Free Full Text]
  29. Ray, K., and Ganguly, R. (1992) J. Biol. Chem. 267,6086-6092 [Abstract/Free Full Text]
  30. Schmidt, C. J., Thomas, T. C., Levine, M. A., and Neer, E. J. (1992) J. Biol. Chem. 267,13807-13810 [Abstract/Free Full Text]
  31. Pronin, A. N., and Gautam, N. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,6220-6224 [Abstract]
  32. Iniguez-Lluhi, J. A., Simon, M. I., Robishaw, J. D., and Gilman, A. G. (1992) J. Biol. Chem. 267,23409-23417 [Abstract/Free Full Text]
  33. Ueda, N., Iniguez-Lluhi, J. A., Lee, E., Smrcka, A. V., Robishaw, J. D., and Gilman, A. G. (1994) J. Biol. Chem. 269,4388-4395 [Abstract/Free Full Text]
  34. Rahmatullah, M., and Robishaw, J. D. (1994) J. Biol. Chem. 269,3574-3580 [Abstract/Free Full Text]
  35. Peng, Y. W., Robishaw, J. D., Levine, M. A., and Yau, K.-W. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,10882-10886 [Abstract]
  36. Hansen, C. A., Schroering, A. G., and Robishaw, J. D. (1995) J. Mol. Cell. Cardiol. 27,471-484 [Medline] [Order article via Infotrieve]
  37. Hansen, C. A., Schroering, A. G., Carey, D. J., and Robishaw, J. D. (1994) J. Cell Biol. 126,811-819 [Abstract]
  38. Kinsella, B. T., Erdman, R. A., and Maltese, W. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,8934-8938 [Abstract]
  39. Lee, R. H., Lieberman, B. S., Yamane, H. K., Bok, D., and Fung, B. K.-K. (1992) J. Biol. Chem. 267,24776-24781 [Abstract/Free Full Text]
  40. Fawzi, A. B., Fay, D. S., Murphy, E. A., Tamir, H., Erdos, J. J., and Northup, J. K. (1991) J. Biol. Chem. 266,12194-12200 [Abstract/Free Full Text]
  41. Bubis, J., and Khorana, H. G. (1990) J. Biol. Chem. 265,12995-12999 [Abstract/Free Full Text]
  42. Garritsen, A., and Simonds, W. F. (1994) J. Biol. Chem. 269,24418-24423 [Abstract/Free Full Text]
  43. Kleuss, C., Scherubl, H., Hescheler, J., Schultz, G., and Wittig, B. (1993) Science 259,832-834 [Medline] [Order article via Infotrieve]
  44. Wilcox, M. D., Dingus, J., Balcueva, E. B., McIntire, W. E., Mehta, N. D., Schey, K. L., Robishaw, J. D., and Hildebrandt, J. D. (1995) J. Biol. Chem. 270,4189-4192 [Abstract/Free Full Text]
  45. Ryba, N. J. P., and Tirindelli, R. (1995) J. Biol. Chem. 270,6757-6767 [Abstract/Free Full Text]
  46. Ong, O. C., Yamane, H. K., Phan, K. B., Fong, H. K. W., Bok, D., Lee, R. H., and Fung, B. K.-K. (1995) J. Biol. Chem. 270,8495-8500 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.